Biochemistry, Genetics and Molecular Biology
Esophagus
100%
Methylation
94%
Microsatellite Instability
61%
Promoter Region
54%
Carcinogenesis
53%
P53
46%
Colon
45%
Loss of Heterozygosity
43%
MicroRNA
43%
Dysplasia
41%
Cancer Cell
38%
Tumor Suppressor Gene
38%
Epigenetics
28%
DNA Methylation
22%
Microsatellite DNA
20%
DNA Mismatch Repair
20%
Messenger RNA
19%
Genetics
18%
Metaplasia
18%
Cell Proliferation
18%
Polymerase Chain Reaction
18%
Catenin
18%
Adenomatous Polyposis Coli
18%
Gene Mutation
18%
Polymerase Chain Reaction
17%
Gene Expression
16%
Exon
15%
Signal Transduction
14%
RNA
14%
Coding Region
13%
CpG Island
13%
Gene Promoter
13%
Point Mutation
12%
cDNA Microarray
12%
Phosphotransferase
12%
Kinase
12%
Microarrays
12%
Proto Oncogene
12%
Tumor Suppressor Protein
11%
Oncogene
11%
Prevalence
11%
Wnt Signaling Pathway
10%
Circular RNA
10%
SUFU
10%
DNA Sequence
9%
Aneuploidy
9%
Gene Locus
9%
Frameshift Mutation
9%
Cadherin
9%
Eicosanoid Receptor
9%
Medicine and Dentistry
Barrett Esophagus
78%
Neoplasm
67%
Esophageal Adenocarcinoma
53%
Dysplasia
51%
Malignant Neoplasm
47%
Esophageal Cancer
44%
Adenocarcinoma
31%
Microsatellite Instability
30%
Esophagus Carcinoma
30%
Methylation
28%
Biological Marker
25%
Carcinogenesis
25%
Promoter Region
24%
Ulcerative Colitis
22%
Esophagus
22%
Gene Expression
22%
Inflammatory Bowel Disease
21%
Esophageal Squamous Cell Carcinoma
19%
Stomach Cancer
19%
microRNA
18%
Colorectal Cancer
16%
Protein P53
16%
Heterozygosity
16%
Squamous Cell Carcinoma
16%
Carcinoma
15%
Cell Line
15%
Disease
15%
Colon Cancer
13%
DNA Methylation
12%
Oncogene
12%
Metaplasia
12%
Cancer Cell
11%
Adenomatous Polyposis Coli
11%
Cancer
11%
Gene Mutation
10%
cDNA Microarray
10%
DNA Mismatch Repair
10%
Proto Oncogene
10%
In Vitro
10%
Organoid
9%
Breast Cancer
9%
Tumor Suppressor Gene
9%
Pancreatitis
9%
Colorectal Tumor
8%
Cell Cycle
8%
Patient with Inflammatory Bowel Disease
6%
Complementary DNA
6%
Epithelial Cell
6%
Polymerase Chain Reaction
6%
Stomach Adenocarcinoma
6%
Keyphrases
Barrett's Esophagus
72%
Esophageal Adenocarcinoma
62%
Esophageal Squamous Cell Carcinoma
49%
Esophageal Cancer
40%
Tumor
32%
Microsatellite Instability-high (MSI-H)
32%
Gastric Cancer
30%
Hypermethylation
30%
Methylation
29%
Esophageal Carcinoma
29%
Ulcerative Colitis
27%
Promoter Methylation
25%
MicroRNA
23%
Loss of Heterozygosity
22%
Tumor Suppressor Gene
22%
Neoplastic Progression
21%
Inflammatory Bowel Disease
20%
Colorectal Cancer
20%
Adenomatous Polyposis Coli
19%
Adenocarcinoma
18%
Adenomatous Polyposis Coli Gene
16%
Dysplasia
15%
Oncogene
15%
Squamous Cell Carcinoma (SqCC)
13%
Human Esophageal Cancer
13%
Gastric Carcinoma
12%
Barrett
12%
High-grade Dysplasia
12%
Colon Cancer
12%
Esophageal Carcinogenesis
12%
Normal Esophagus
12%
Risk of Progression
12%
Cyclooxygenase-2
12%
Esophageal Tumor
11%
Barrett's Metaplasia
11%
Polymerase Chain Reaction
11%
Adenocarcinoma Cells
10%
Allelic Loss
10%
Complementary DNA (cDNA)
10%
Catenin
9%
Tumor Protein p53 (TP53)
9%
Colitis-associated Dysplasia
9%
Gene Promoter
9%
MRNA Expression
9%
Human Gastric Cancer
9%
Human Gastric Carcinoma
9%
Breast Cancer
8%
Early Events
8%
Esophageal Cancer Cells
8%
Overexpression
8%
